Welcome to LookChem.com Sign In|Join Free
  • or

Encyclopedia

Sivelestat sodium

Base Information
  • Chemical Name:Sivelestat sodium
  • CAS No.:201677-61-4
  • Molecular Formula:C20H21N2NaO7S.4(H2O)
  • Molecular Weight:528.51
  • Hs Code.:2935909099
  • Mol file:201677-61-4.mol
Sivelestat sodium

Synonyms:Glycine,N-[2-[[[4-(2,2-dimethyl-1-oxopropoxy)phenyl]sulfonyl]amino]benzoyl]-,monosodium salt, tetrahydrate (9CI);Elaspol;Elaspol 100;LY 544349 sodiumtetrahydrate;Sivelestat sodium tetrahydrate;

Suppliers and Price of Sivelestat sodium
Supply Marketing:
Business phase:
The product has achieved commercial mass production*data from LookChem market partment
Manufacturers and distributors:
  • Manufacture/Brand
  • Chemicals and raw materials
  • Packaging
  • price
  • DC Chemicals
  • Sivelestat sodium salt hydrate >98%
  • 250 mg
  • $ 400.00
  • DC Chemicals
  • Sivelestat sodium salt hydrate >98%
  • 100 mg
  • $ 200.00
  • CSNpharm
  • SivelestatSodiumTetrahydrate
  • 10mg
  • $ 76.00
  • CSNpharm
  • SivelestatSodiumTetrahydrate
  • 5mg
  • $ 45.00
  • CSNpharm
  • SivelestatSodiumTetrahydrate
  • 50mg
  • $ 262.00
  • CSNpharm
  • SivelestatSodiumTetrahydrate
  • 100mg
  • $ 381.00
  • Crysdot
  • Sivelestatsodiumtetrahydrate 98+%
  • 100mg
  • $ 358.00
  • Crysdot
  • Sivelestatsodiumtetrahydrate 98+%
  • 50mg
  • $ 247.00
  • ChemScene
  • Sivelestat(sodiumtetrahydrate) 99.91%
  • 10mg
  • $ 84.00
  • ChemScene
  • Sivelestat(sodiumtetrahydrate) 99.91%
  • 50mg
  • $ 288.00
Total 59 raw suppliers
Chemical Property of Sivelestat sodium
Chemical Property:
  • PSA:187.00000 
  • LogP:2.20610 
  • Storage Temp.:Sealed in dry,Room Temperature 
  • Solubility.:Soluble in DMSO (up to 20 mg/ml). 
Purity/Quality:

99% *data from raw suppliers

Sivelestat sodium salt hydrate >98% *data from reagent suppliers

Safty Information:
  • Pictogram(s):  
  • Hazard Codes: 
MSDS Files:

SDS file from LookChem

Total 1 MSDS from other Authors

Useful:
  • Description Sivelestat is an acyl enzyme inhibitor of neutrophil elastase, developed as an injectable formulation for the treatment of acute lung injury associated with systemic inflammatory response syndrome. A neutrophil predominant inflammation associated with excessive release of human neutrophil elastase (HNE) from azurophilic granules is capable of damaging both the lung parenchymal cells and the extracellular matrix allowing an alveolar capillary barrier disruption. Sivelestat is a sulfonanilide-containing pivaloyloxy benzene derivative prepared in a three step synthesis. This agent acts as a reversible and selective inhibitor of HNE with an lG.0 value of 0.044 PM. Sivelestat has exhibited potent protective effects against various causes of lung injuries in animal models. In an acid-induced acute lung injury model in conscious hamster, administration of sivelestat for 48 h following HCI instillation, dose-dependently reduced mortality and significantly improved the protein levels in bronchoalveolar lavage fluids and pulmonary artery pressure. In a similar study, the agent inhibited the endotoxin-induced acute lung dysfunctions (marked elevation of pulmonary vascular permeability, leukocyte migration, hemorrhage and parenchymal injury) in different animal species. Moreover, in a cardiopulmonary bypass model in dog, sivelestat ameliorated the respiratory index and interstitial-intra-alveolar edema. Sivelestat has a relatively poor bioavailability, due to an extensive first-pass metabolism and is easily hydrolyzed in vitro to an inactive metabolite. In two animal species, the half-life time was approximately 5-7 min. Clinical trials have shown that treatment with the agent improves respiratory function and facilitates early removal of patients from mechanical ventilation. However, in the last clinical study, conducted by Eli Lilly in patients with acute lung injury, no difference in mortality and safety was seen between sivelestat and placebo. Sivelestat is an inhibitor of neutrophil elastase (IC50 = 44 nM for the human enzyme). It is selective for neutrophil elastase over trypsin, thrombin, plasmin, kallikrein, chymotrypsin, and cathepsin G at 100 μM. Sivelestat inhibits the formation of neutrophil extracellular traps (NETs) induced by ionomycin (Item Nos. 10004974 | 11932) in isolated mouse neutrophils. It decreases LPS-induced NF-κB nuclear translocation in isolated rat pulmonary microvascular endothelial cells (PMVECs) at 50 mM. Sivelestat (10 mg/kg) reduces pulmonary edema, increases in the number of cells in the lung tissue positive for myeloperoxidase (MPO), a marker of neutrophil infiltration, and the severity of lung injury in a rat model of LPS-induced acute lung injury.
Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 201677-61-4